Author David Fajgenbaum
#NetGalley
David Fajgenbaum, MD, MBA, MSc is one of the youngest individuals to be appointed to the faculty at Penn Medicine. Co-founder and executive director of the Castleman Disease Collaborative Network and an NIH-funded physician-scientist, he has dedicated his life to discovering new treatments and cures for deadly disorders like Castleman disease, which he was diagnosed with during medical school. He is in the top 1% youngest grant awardees of an R01, one of the most competitive and sought after grants in all of biomedical research. Dr. Fajgenbaum has been recognized on the Forbes 30 Under 30 healthcare list, as a top healthcare leader by Becker's Hospital Review, and one of the youngest people ever elected as a Fellow of the College of Physicians of Philadelphia, the nation's oldest medical society. He was one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Winner of the Rare Champion of Hope Science award, Dr. Fajgenbaum has been profiled in a cover story by the New York Times as well as profiles by Reader's Digest, Science, and the Today Show. Dr. Fajgenbaum earned his BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I College Quarterback, state-champion weight lifter, and co-founder of a national grief support network.
